Cortney Inman

ID:LEX-AR-KQ2YF0N2

Claimed Record

Organization: Sheppard, Mullin, Richter & Hampton LLP

Professional Bio

Cortney Inman is an associate in the Governmental Practice Group in the firm's Washington, D.C. office and a member of the FDA Regulatory and Life Sciences teams.

FDA Releases Final Guidance on Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements

Food, Drug & Agriculture · July 14, 2023

FDA Issues Proposed Rule for Standardized and Accessible Patient Medication Information

Health Care and Life Sciences · June 13, 2023

FDA Cracking Down on Unapproved HCT/Ps with Fourth Untitled Letter of 2023

Health Care and Life Sciences · June 2, 2023

OIG Advisory Opinion Alert: Medical Flights for Patient Access

Healthcare Law Blog · March 8, 2023

OIG Advisory Opinion Alert: Medical Flights for Patient Access

Health Care and Life Sciences · March 7, 2023

Practice Areas

Health Care and Life Sciences

Jurisdictions

North America

United States